This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Michael Leek
Chief Executive Officer at TC BioPharm


Recently presented the 'Scottish Life-Sciences Entrepreneurial Business Leadership' award; Michael is CEO of TC BioPharm, developing clinical phase CAR-T cancer immunotherapies.
He has previously worked as CEO of an orthobiologicals company, and with a clinical team developing an autologous infusion of stem cells to initiate regeneration of new hepatic tissue. Michael was jointly responsible for moving Intercytex from a pre-clinical research company, to an AIM-listed biotech with several cell therapy products in the clinic. Michael is also a Fellow of the Royal Society of Medicine and Honorary Lecturer at the University of Aberdeen, School of Medical Sciences

Agenda Sessions

  • Gamma Delta Case Study